Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Cisplatin - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for cisplatin?

Cisplatin is the generic ingredient in three branded drugs marketed by Bedford, Teva Pharms Usa, Fresenius Kabi Usa, West-ward Pharms Int, Pharmachemie Bv, Hq Spclt Pharma, Mylan Labs Ltd, and Accord Hlthcare, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for cisplatin. Eight suppliers are listed for this compound.

Summary for Generic Name: cisplatin

Tradenames:3
Patents:1
Applicants:8
NDAs:8
Drug Master File Entries: see list14
Suppliers / Packagers: see list8
Clinical Trials: see list944
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:cisplatin at DailyMed

Pharmacology for Ingredient: cisplatin

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hq Spclt Pharma
PLATINOL
cisplatin
INJECTABLE;INJECTION018057-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Pharmachemie Bv
CISPLATIN
cisplatin
INJECTABLE;INJECTION074656-001May 16, 2000RXNoNo► Subscribe► Subscribe
Hq Spclt Pharma
PLATINOL
cisplatin
INJECTABLE;INJECTION018057-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
West-ward Pharms Int
CISPLATIN
cisplatin
INJECTABLE;INJECTION075036-001Nov 7, 2000RXNoNo► Subscribe► Subscribe
Hq Spclt Pharma
CISPLATIN
cisplatin
INJECTABLE;INJECTION018057-004Nov 8, 1988RXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: cisplatin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Hq Spclt Pharma
PLATINOL
cisplatin
INJECTABLE;INJECTION018057-002Approved Prior to Jan 1, 19824,177,263► Subscribe
Hq Spclt Pharma
PLATINOL-AQ
cisplatin
INJECTABLE;INJECTION018057-003Jul 18, 19845,562,925► Subscribe
Hq Spclt Pharma
PLATINOL-AQ
cisplatin
INJECTABLE;INJECTION018057-003Jul 18, 19844,177,263► Subscribe
Hq Spclt Pharma
PLATINOL-AQ
cisplatin
INJECTABLE;INJECTION018057-003Jul 18, 19844,310,515► Subscribe
Hq Spclt Pharma
PLATINOL
cisplatin
INJECTABLE;INJECTION018057-001Approved Prior to Jan 1, 19824,177,263► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc